Skip to main content
Clinical Trials/NCT01937936
NCT01937936
Completed
Not Applicable

Stress and Health in Family Caregivers of Persons With Heart Failure

University of California, Los Angeles2 sites in 1 country50 target enrollmentSeptember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stress
Sponsor
University of California, Los Angeles
Enrollment
50
Locations
2
Primary Endpoint
Salivary cortisol
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Family caregivers are vulnerable to health problems because of the stress and demands of their role as a caregiver. With the growing incidence of heart failure (HF) and the anticipated growth in the aging population, the number of HF caregivers is expected to rise. This study will pilot test a cognitive behavioral intervention designed to reduce stress among HF caregivers, which will ultimately contribute to promoting health and quality of life among HF caregivers and their loved ones with HF.

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
May 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Boyoung Hwang, PhD, RN

Assistant Professor

University of California, Los Angeles

Eligibility Criteria

Inclusion Criteria

  • 21 years or older
  • Having primary or secondary diagnosis of HF (NYHA class II-IV)
  • Having a family member or friend providing care for them at home
  • Being able to communicate in English

Exclusion Criteria

  • Being on the transplant list
  • Having terminal illness (e.g., terminal cancer)
  • Caregiver Inclusion Criteria:
  • 21 years or older
  • Having the primary responsibility for the care of the patient for at least 6 months
  • Living in the greater Los Angeles area
  • Being able to communicate in English
  • Caregiver Exclusion Criteria:
  • Being a paid caregiver (an individual who is hired to provide care for the patient)
  • Having terminal illness (e.g., terminal cancer) or a serious medical condition that requires ongoing medical care (e.g., cancer requiring ongoing chemotherapy or radiation therapy)

Outcomes

Primary Outcomes

Salivary cortisol

Time Frame: 8 weeks

Secondary Outcomes

  • Health care usage(6 months)
  • Perceived stress(8 weeks and 6 months)
  • Depressive symptoms(8 weeks and 6 months)
  • Health-related quality of life(8 weeks and 6 months)

Study Sites (2)

Loading locations...

Similar Trials